These agents include semaglutide (Ozempic for diabetes, Wegovy for obesity), liraglutide (Victoza for diabetes, Saxenda for obesity), dulaglutide (Trulicity, diabetes only), and tirzepatide (Mounjaro for diabetes, Zepbound for obesity)with tirzepatide being a dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 receptor agonist
Prescriptions may go unfilled once patients realize that their insurance companies wont foot the bill
These appointments can provide valuable opportunities to assess weight loss goals, discuss any challenges faced, and evaluate the effectiveness of the medication
We want you to find the right peptide tools for your lab, ensuring every step of your research, including your KLOW dosage guide, is built on a foundation of excellence
This reflects the chronic nature of obesity rather than medication failure
Content and tools are not medical advice, diagnosis, treatment, prescribing guidance, dosing guidance, pharmacy guidance, or emergency care